These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Dalton WS, Cress AE, Alberts DS, Trent JM. Cancer Res; 1988 Apr 01; 48(7):1882-8. PubMed ID: 2894893 [Abstract] [Full Text] [Related]
4. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity. Aksentijevich I, Cardarelli CO, Pastan I, Gottesman MM. Clin Cancer Res; 1996 Jun 01; 2(6):973-80. PubMed ID: 9816258 [Abstract] [Full Text] [Related]
6. Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Benchekroun MN, Schneider E, Safa AR, Townsend AJ, Sinha BK. Mol Pharmacol; 1994 Oct 01; 46(4):677-84. PubMed ID: 7969046 [Abstract] [Full Text] [Related]
9. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region. Flahaut M, Mühlethaler-Mottet A, Martinet D, Fattet S, Bourloud KB, Auderset K, Meier R, Schmutz NB, Delattre O, Joseph JM, Gross N. Genes Chromosomes Cancer; 2006 May 01; 45(5):495-508. PubMed ID: 16450357 [Abstract] [Full Text] [Related]
10. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS. Cancer Res; 1996 Dec 01; 56(23):5435-42. PubMed ID: 8968098 [Abstract] [Full Text] [Related]
11. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Ramachandran C, Wellham LL. Anticancer Res; 2003 Dec 01; 23(3B):2681-90. PubMed ID: 12894558 [Abstract] [Full Text] [Related]
12. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance. Quattrone A, Papucci L, Morganti M, Coronnello M, Mini E, Mazzei T, Colonna FP, Garbesi A, Capaccioli S. Oncol Res; 1994 Dec 01; 6(7):311-20. PubMed ID: 7865906 [Abstract] [Full Text] [Related]
13. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides. Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N. Chin Med J (Engl); 2001 Sep 01; 114(9):929-32. PubMed ID: 11780384 [Abstract] [Full Text] [Related]
14. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Baldini N, Scotlandi K, Serra M, Shikita T, Zini N, Ognibene A, Santi S, Ferracini R, Maraldi NM. Eur J Cell Biol; 1995 Nov 01; 68(3):226-39. PubMed ID: 8603675 [Abstract] [Full Text] [Related]
15. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Mi Q, Cui B, Silva GL, Lantvit D, Lim E, Chai H, You M, Hollingshead MG, Mayo JG, Kinghorn AD, Pezzuto JM. Cancer Res; 2001 May 15; 61(10):4030-7. PubMed ID: 11358822 [Abstract] [Full Text] [Related]
19. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells. Brouillard F, Tondelier D, Edelman A, Baudouin-Legros M. Cancer Res; 2001 Feb 15; 61(4):1693-8. PubMed ID: 11245485 [Abstract] [Full Text] [Related]
20. Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. Taguchi Y, Kino K, Morishima M, Komano T, Kane SE, Ueda K. Biochemistry; 1997 Jul 22; 36(29):8883-9. PubMed ID: 9220975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]